Page last updated: 2024-10-31

nevirapine and Syphilis

nevirapine has been researched along with Syphilis in 5 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Syphilis: A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.

Research Excerpts

ExcerptRelevanceReference
"We report a case in which an HIV-positive man developed general malaise, skin rash and biochemical hepatitis within days of starting a nevirapine-based antiretroviral treatment regimen."7.80Rash and hepatitis within days of starting a new antiretroviral regimen: nevirapine hypersensitivity, secondary syphilis or both? ( Helbert, MR; Higgins, SP; Komolafe, AJ; Saxon, CJ, 2014)
"Syphilis is associated with increased human immunodeficiency virus acquisition and sexual transmission; we examined impact on human immunodeficiency virus mother-to-child transmission among mother-infant pairs enrolled in the India Six-Week Extended-Dose Nevirapine study."3.85Maternal Syphilis: An Independent Risk Factor for Mother to Infant Human Immunodeficiency Virus Transmission. ( Bharadwaj, R; Bhat, J; Bhosale, R; Bollinger, R; Gupta, A; Gupte, N; Kinikar, A; Kulkarni, V; Mave, V; McIntire, KN; Patil, S; Suryavanshi, N, 2017)
"We report a case in which an HIV-positive man developed general malaise, skin rash and biochemical hepatitis within days of starting a nevirapine-based antiretroviral treatment regimen."3.80Rash and hepatitis within days of starting a new antiretroviral regimen: nevirapine hypersensitivity, secondary syphilis or both? ( Helbert, MR; Higgins, SP; Komolafe, AJ; Saxon, CJ, 2014)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Menegotto, M1
Magdaleno, AM1
da Silva, CLO1
Friedrich, L1
da Silva, CH1
Kinikar, A1
Gupte, N1
Bhat, J1
Bharadwaj, R1
Kulkarni, V1
Bhosale, R1
McIntire, KN1
Mave, V1
Suryavanshi, N1
Patil, S1
Bollinger, R1
Gupta, A1
Saxon, CJ1
Helbert, MR1
Komolafe, AJ1
Higgins, SP1
Shilaih, M1
Marzel, A1
Braun, DL1
Scherrer, AU1
Kovari, H1
Young, J1
Calmy, A1
Darling, K1
Battegay, M1
Hoffmann, M1
Bernasconi, E1
Thurnheer, MC1
Günthard, HF1
Kouyos, RD1
Welty, TK1
Bulterys, M1
Welty, ER1
Tih, PM1
Ndikintum, G1
Nkuoh, G1
Nkfusai, J1
Kayita, J1
Nkengasong, JN1
Wilfert, CM1

Other Studies

5 other studies available for nevirapine and Syphilis

ArticleYear
Mother-to-Child HIV Transmission among Pregnant Women in a City with the Highest Rates of HIV in Brazil.
    American journal of perinatology, 2022, Volume: 39, Issue:13

    Topics: Brazil; Child; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmiss

2022
Maternal Syphilis: An Independent Risk Factor for Mother to Infant Human Immunodeficiency Virus Transmission.
    Sexually transmitted diseases, 2017, Volume: 44, Issue:6

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials, Phase III as Topic; Cost-Benefit Anal

2017
Rash and hepatitis within days of starting a new antiretroviral regimen: nevirapine hypersensitivity, secondary syphilis or both?
    International journal of STD & AIDS, 2014, Volume: 25, Issue:3

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Diagnosis, Differential; Exanthema; Hepatitis; HIV Inf

2014
Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals.
    Medicine, 2017, Volume: 96, Issue:2

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Comorbidity; Female; Heterosexuality;

2017
Integrating prevention of mother-to-child HIV transmission into routine antenatal care: the key to program expansion in Cameroon.
    Journal of acquired immune deficiency syndromes (1999), 2005, Dec-01, Volume: 40, Issue:4

    Topics: Adolescent; Adult; Age Factors; Anti-HIV Agents; Cameroon; Counseling; Female; HIV Infections; Human

2005